Combined antiangiogenic therapy is superior to single inhibitors in a model of renal cell carcinoma

Erstveröffentlichung
2008Authors
Bartsch, Jr., Georg
Eggert, Katharina
Soker, Shay
Bokenteyer, Carsten
Hautmann, Richard
Wissenschaftlicher Artikel
Published in
The Journal of Urology ; 179 (2008), 1. - S. 326-332. - ISSN 0022-5347. - eISSN 1527-3792
Link to publication
https://dx.doi.org/10.1016/j.juro.2007.08.086Institutions
UKU. Klinik für Urologie und KinderurologieSubject headings
[Free subject headings]: kidney | carcinoma | renal cell | endostatins | neuropilins | thrombospondins | ENDOTHELIAL GROWTH-FACTOR | INTERFERON-ALPHA | IN-VIVO | ENDOSTATIN | NEUROPILIN-1 | TRIAL | BEVACIZUMAB | PROGRESSION[DDC subject group]: DDC 610 / Medicine & health